Valuation Imexpharm Corporation

Stocks

End-of-day quote Ho Chi Minh S.E. 02/10/2026			5-day change	1st Jan Change
36,600.00 ^VND	+0.27%		-0.81%	-30.29%

07-20	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-02	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,636,728	-
Change	-	-22.62%	-1.28%	82.69%	11.7%	-30.29%	-
Enterprise Value (EV)	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,636,728	5,636,728
Change	-	-22.62%	-1.28%	82.69%	11.7%	-30.29%	0%
P/E	29.9x	17.2x	15.6x	24.3x	26.6x	15.8x	14.6x
PBR	2.89x	2.11x	1.9x	3.32x	-	2.24x	2.05x
PEG	-	0.5x	1.68x	1.4x	11.68x	1x	1.73x
Capitalization / Revenue	4.1x	2.44x	1.99x	3.28x	3.31x	2.12x	1.96x
EV / Revenue	0x	0x	0x	0x	0x	2.12x	1.96x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	11.5x	10.6x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	649.4	-	-	500	-	1,000	1,000
Rate of return	1.93%	-	-	1.06%	-	2.74%	2.74%
EPS ²	1,126	1,513	1,653	1,932	1,976	2,304	2,499
Distribution rate	57.7%	-	-	25.9%	-	43.4%	40%
Net sales ¹	1,266,597	1,643,707	1,994,037	2,205,120	2,441,085	2,659,000	2,881,000
EBITDA	299,271	-	457,049	521,703	-	-	-
EBIT ¹	234,475	300,992	374,407	403,285	445,003	490,000	532,000
Net income ¹	189,095	233,964	299,556	320,862	349,138	394,000	428,000
Net Debt	-	-	-	-	-	-	-
Reference price ²	33,679.65	26,060.61	25,727.27	47,000.00	52,500.00	36,500.00	36,500.00
Nbr of stocks (in thousands)	154,011	154,011	154,007	154,009	154,009	154,009	-
Announcement Date	1/20/22 A	1/17/23 A	1/19/24 A	1/20/25 A	1/20/26 A	-	-

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IMEXPHARM CORPORATION	15.84x	-	-	-	216M
ELI LILLY AND COMPANY	32.69x	11.85x	24.08x	0.6%	1,025B
JOHNSON & JOHNSON	28.77x	6.4x	17.91x	2.06%	623B
ABBVIE INC.	32.89x	7.71x	15.93x	2.67%	459B
MERCK & CO., INC.	104.62x	5.85x	24.82x	2.37%	355B
ROCHE HOLDING AG	18.99x	4.63x	11.47x	2.87%	336B
NOVARTIS AG	20.13x	5.23x	12.95x	3.06%	270B
ASTRAZENECA PLC	20.27x	4.21x	12x	2.1%	247B
AMGEN INC.	25.72x	6.72x	11.97x	2.48%	220B
GILEAD SCIENCES, INC.	-44.61x	6.5x	25.4x	2.23%	183B
Average	25.53x	6.57x	17.39x	2.27%	371.84B
Weighted average by Cap.	31.73x	7.64x	18.71x	1.95%